Non-valvular atrial fibrillation - Globe Thesis

Keyword [Non-valvular atrial fibrillation] Result: 21 - 40 \| Page: 2 of 10
21.	Association Of T393C Single Nucleotide Polymorphism In The GNAS1 Gene With Non-Valvular Atrial Fibrillation
22.	Clinical Value Of Changes Of Plasma D-dimmer And Thrombin Antithrombin Ⅲ Complexes Level In Patients With Non-Valvular Atrial Fibrillation
23.	The Clinical Application Of Inflammatory Factors In Assessing The Risk Of Cerebral Embolism Result From Non-valvular Atrial Fibrillation
24.	Retrospective Study Of Application Status In Patients With Non-valvular Atrial Fibrillation Warfarin
25.	Prediction Of Left Atrial Thrombi In Non-valvular Atrial Fibrillation
26.	Meta Analysis:Oral Anticoagulants Versus Antiplatelet Therapy For The Primary Prevention Of Stroke In Patients With Non-valvular Atrial Fibrillation
27.	Retrospective Analysis Of Subtypes And Risk Factors Of Ischemic Stroke In Patients With Non-valvular Atrial Fibrillation
28.	Non Valvular Disease, The Atrial Fibrillation And It Is Necessary To Study The Combination
29.	The Correlation Of CYP2C9、VKORC1、CYP4F2Polymorphisms With Warfarin Does In Fujian Han Population
30.	Predictors Of Left Atrial Thrombus In Patients With Non-valvular Atrial Fibrillation
31.	The Clinical Study Of Different Antithrombotic Therapies In Different Risk Patients With Non-valvular Atrial Fibrillation
32.	Analyze The Characteristic Of Risk Factors And Imaging In Ischemic Stroke Patients With Non Valvular Atrial Fibrillation With Cerebral Arterial Stenosis
33.	The Efficacy And Safety Of Anticoagulation Therapy By Warfarin Sodium And Dabigatran Etexilate In Patients With Non-valvular Atrial Fibrillation
34.	The Risk Factor Analysis For Stroke In Non-valvular Atrial Fibrillation Patients With Low-intermediate Risk CHADS2Score
35.	Applications Commonly Used Antithrombotic Drugs In Patients With Atrial Fibrillation With Chronic Kidney Disease
36.	The Investigation And Analysis Of Anticoagulation In Huangpu District Inpatients With Non-valvular Atrial Fibrillation
37.	Relevant Risk Factors Analysis Of The Stroke In The Non-valvular Atrial Fibrillation
38.	Compare Of Stroke Risk Assessment Systems And Analyze Of Anticoagulation Therapy In Patients With Non-valvular Atrial Fibrillation
39.	Comparison Of The Safety And Efficacy Of New Oral Anticoagulants With Warfarin In Patients With Atrial Fibrillation:A Meta-analysis
40.	Investigation Of Stroke Risk Assessment Methods For Non-valvular Atrial Fibrillation Patients
<<First <Prev Next> Last>> Jump to